Very excited to share our review on "Metabolites as agents and targets for cancer immunotherapy" in @NatRevDrugDisc! read it here: https://t.co/zYlOay0tdP
@SpringerNature@KlinPharm
Huge congratulations to Prof. Sebastian Kobold for receiving an @ERC_Research consolidator grant for his project: CATACLIS - Cancer tailored next generation cellular therapies💐@LMU_Muenchen#ERC
We’re excited to present our most recent preprint on bioRxiv “Multimodal single-cell profiling of T cell specificity and reactivity in lung cancer ” https://t.co/xmL6snv7hy
Great collaboration with Hutter lab. Philip Schmassmann identifies Sig9 as new target in GBM.
#glycotime
Targeting the Siglec–sialic acid axis promotes antitumor immune responses in preclinical models of glioblastoma | Science Translational Medicine https://t.co/0k78JB7A5l
The Bassermann lab @TumTransla has several open #positions in #Munich#postdoc
https://t.co/ciI4DMZ821
#PhD
https://t.co/XhGQjHtw08
and a technical assistant
https://t.co/uE0prj8Dva
Are you a science enthusiast, interested in cancer biology and protein turnover grab a seat🍻
We are excited that our latest study on cDC1-mediated coordination of anti-cancer responses by tumor-infiltrating TCF1+stem-like CD8+ T cells, led by @PhilippaMeiser is now published OPEN ACCESS in @Cancer_Cell! https://t.co/HRLzKv6QDs 🧵👇1/n
We are thrilled that our recent study lead by @BayerlFelix is out in @ImmunityCP today. We addressed the question how cDC1 dysfunction is regulated in tumors and to which extent this contributes to cancer immune evasion. It is Open Access!👇
https://t.co/Kjm87tegxm
A short 🧵:
Delighted to share our latest research following T cell receptor (TCR) by 3D TEM and showing ectocytosis makes TCR signalling self limiting at the immune synapse.
Many thanks to everyone involved.
@griffiths_lab https://t.co/5kNV1Sf9OW
Thrilled to share my Perspective on how #TissueImmunity selectively restrains the growth of metastases - an exciting avenue for developing #Immunotherapies for long-lasting control of #Metastasis
Thanks Lucy Bird and @NatRevImmunol for the opportunity!
👉https://t.co/zeHt9atpQ5
Eine Forschungsgruppe der @UniBasel hat ein Gen identifiziert, welches T-Lymphozyten in die Erschöpfung treibt. Dies schafft neue Ansatzpunkte für wirksamere Immuntherapien.
@DepBiomedicine@snf_ch
https://t.co/PpW0bef7Us